|
2025 Journal Article An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancerRuan, Qi, Chen, Tao, Kim, Minwoo, Yang, Haotian, Sinha, Debottam, He, Yaowu, Burke, Lez, Wickramasuriya, Lashith, Cao, Lu, Yan, Weikang, Hooper, John, Wang, Haolu, Bridle, Kim, Chandra, Janin, Crawford, Darrell and Liang, Xiaowen (2025). An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer. Hepatology PMID 8302946. doi: 10.1097/hep.0000000000001639 |
|
2023 Conference Publication Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancerRuan, Qi, Cao, Lu, Yang, Haotian, Burke, Leslie, Bridle, Kim, Crawford, Darrell and Liang, Xiaowen (2023). Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancer. EASL Congress 2023, Vienna, Austria, 21 - 24 June 2023. Amsterdam, Netherlands: Elsevier. |
